Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-02-07

Clinical Trial Update: BLOSSOM: Behavioral Modification and Lorcaserin Second Study for Obesity Management [Phase 3]

View source ↗

Summary

Phase 3 trial update for BLOSSOM studying lorcaserin in obesity management; study completed with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lorcaserin (lorcaserin)

Snippet

Sponsor: Eisai Inc. | Conditions: Obesity | Phase 3 | Status: COMPLETED | Results posted: 2013-02-07